Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fibrocell Science Inc (NASDAQ:FCSC)

2.09
Delayed Data
As of 3:59pm ET
 +0.02 / +0.97%
Today’s Change
1.98
Today|||52-Week Range
7.60
-54.07%
Year-to-Date

Today’s Trading

Previous close2.07
Today’s open2.07
Day’s range2.01 - 2.12
Volume114,515
Average volume (3 months)167,197
Market cap$90.9M
Dividend yield--
Data as of 3:59pm ET, 05/25/2016

Growth & Valuation

Earnings growth (last year)-22.23%
Earnings growth (this year)+40.59%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+173.33%
P/E ratioNM
Price/Sales391.66
Price/Book6.40

Competitors

 Today’s
change
Today’s
% change
RNVARennova Health Inc0.000.00%
RPBIFResponse Biomedical ...0.000.00%
UBICUBIC Inc-0.75-3.80%
CLDXCelldex Therapeutics...+0.01+0.24%
Data as of 3:59pm ET, 05/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$492.0K
Annual profit (last year)-$34.5M
Net profit margin-7,002.64%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David M. Pernock
CFO, Treasurer &
Senior Vice President
Keith Alan Goldan
Corporate headquarters
Exton, Pennsylvania

Forecasts

Partner Offers

Search for Jobs